X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (130) 130
index medicus (114) 114
female (94) 94
male (84) 84
radiology, nuclear medicine & medical imaging (81) 81
middle aged (78) 78
aged (72) 72
adult (65) 65
article (56) 56
aged, 80 and over (45) 45
oncology (44) 44
abridged index medicus (39) 39
computed tomography (38) 38
lung cancer (30) 30
radiology (29) 29
tomography, x-ray computed (29) 29
retrospective studies (28) 28
care and treatment (26) 26
diagnosis (25) 25
respiratory system (24) 24
treatment outcome (24) 24
cancer (23) 23
tomography, x-ray computed - methods (23) 23
disease (21) 21
immunotherapy (21) 21
cell lung-cancer (20) 20
carcinoma, non-small-cell lung - pathology (19) 19
lung neoplasms - drug therapy (19) 19
lung neoplasms - pathology (19) 19
carcinoma, non-small-cell lung - drug therapy (18) 18
high-resolution ct (18) 18
analysis (17) 17
lung (17) 17
computed-tomography (16) 16
lung - diagnostic imaging (15) 15
physics (15) 15
solid tumors (15) 15
ct imaging (14) 14
lung cancer, non-small cell (14) 14
melanoma (14) 14
open-label (14) 14
disease progression (13) 13
idiopathic pulmonary-fibrosis (13) 13
lung diseases (13) 13
nivolumab (13) 13
pneumonitis (13) 13
recist (13) 13
tumors (13) 13
cohort studies (12) 12
guideline version 1.1 (12) 12
interstitial lung disease (12) 12
radiography (12) 12
smoking (12) 12
therapy (12) 12
tumor response (12) 12
calculating (11) 11
chemotherapy (11) 11
computing (11) 11
counting (11) 11
helical ct (11) 11
ipilimumab (11) 11
lung neoplasms - diagnostic imaging (11) 11
magnetic resonance imaging (11) 11
molecular targeted therapy (11) 11
non-small cell lung cancer (11) 11
pneumonia (11) 11
research (11) 11
risk factors (11) 11
survival (11) 11
critical care medicine (10) 10
erlotinib (10) 10
lung neoplasms - genetics (10) 10
medical research (10) 10
patients (10) 10
performing operations (10) 10
transporting (10) 10
1st-line treatment (9) 9
advanced melanoma (9) 9
carcinoma, non-small-cell lung - diagnostic imaging (9) 9
carcinoma, non-small-cell lung - genetics (9) 9
emphysema (9) 9
gefitinib (9) 9
health aspects (9) 9
interstitial lung abnormalities (9) 9
lung diseases - diagnostic imaging (9) 9
mutation (9) 9
neoplasm staging (9) 9
protein kinase inhibitors - therapeutic use (9) 9
reproducibility of results (9) 9
acquired-resistance (8) 8
antibodies, monoclonal - adverse effects (8) 8
chest (8) 8
electricity (8) 8
exhalation (8) 8
follow-up studies (8) 8
immunology (8) 8
lung-cancer (8) 8
medical imaging (8) 8
medicine, experimental (8) 8
metastatic melanoma (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Japan Review, ISSN 0915-0986, 1/2019, Issue 32, pp. 107 - 126
Renowned manga artist Mizuki Shigeru’s (1922–2015) multiple wartime memoirs and travelogues of his time in New Britain Island, Papua New Guinea, comprise a... 
Journal Article
RADIOLOGY, ISSN 0033-8419, 09/2019, Volume 292, Issue 3, pp. 750 - 751
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2016, Volume 34, Issue 28, pp. 3480 - 3481
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 20, pp. 1992 - 1994
To the Editor: Mok et al. (Feb. 16 issue)1 report on the use of osimertinib in patients in the AURA3 trial who had lung cancer and a p.Thr790Met point mutation... 
Inhibitor drugs | Epidermal growth factor receptors | Lung cancer | Cancer therapies
Journal Article
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 05/2018, Volume 38, Issue 38, pp. 1019 - 1029
Objective assessment of tumor responses and treatment results has been the basis for the advancement of cancer therapies, and imaging plays a key role to... 
Neoplasms - therapy | Prognosis | Humans | Immunotherapy | Treatment Outcome | Combined Modality Therapy - methods | Disease Management | Neoplasms - diagnosis | Molecular Targeted Therapy | Precision Medicine - methods | Practice Guidelines as Topic
Journal Article
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 12/2016, Volume 4, Issue 1
Journal Article
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 06/2016, Volume 4, Issue 1, p. 30
The recent study by Hodi et al. published in the Journal of Clinical Oncology has evaluated unconventional response patterns during PD-1 inhibitor therapy... 
CELL LUNG-CANCER | CRITERIA | VARIABILITY | SOLID TUMORS | ONCOLOGY | IMMUNOTHERAPY | GUIDELINE VERSION 1.1 | RECIST PROGRESSION | SCANS | IMMUNOLOGY | RADIOLOGISTS | MEDICINE | Care and treatment | Immune response | Analysis | Cancer | Studies | Oncology | Cancer therapies | Melanoma
Journal Article
Journal Article
Radiology, ISSN 0033-8419, 2014, Volume 271, Issue 1, pp. 6 - 27
Tumor response assessment has been a foundation for advances in cancer therapy. Recent discoveries of effective targeted therapy for specific genomic... 
Lung Neoplasms - genetics | Diagnostic Imaging | Contrast Media | Outcome Assessment (Health Care) | Genomics | Humans | Lung Neoplasms - therapy | Lung Neoplasms - diagnosis | Radiopharmaceuticals | Reviews and
Journal Article
Journal Article
Nature, ISSN 0028-0836, 03/2012, Volume 483, Issue 7391, pp. 613 - 617
Targeted therapies have demonstrated efficacy against specific subsets of molecularly defined cancers(1-4). Although most patients with lung cancer are... 
SURVIVAL | VOLUME MEASUREMENT | GEFITINIB | ACTIVATION | METAANALYSIS | ADENOCARCINOMA | MULTIDISCIPLINARY SCIENCES | ARRY-142886 | STANDARDIZED UPTAKE VALUE | DOCETAXEL | MOUSE MODELS | Lung Neoplasms - drug therapy | Protein-Serine-Threonine Kinases - deficiency | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Lung Neoplasms - metabolism | ras Proteins - metabolism | Tomography, X-Ray Computed | Positron-Emission Tomography | Taxoids - therapeutic use | Biomarkers, Tumor - metabolism | Drug Evaluation, Preclinical | Benzimidazoles - therapeutic use | Disease Models, Animal | Proto-Oncogene Proteins p21(ras) - metabolism | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Pharmacogenetics - methods | Reproducibility of Results | Lung Neoplasms - enzymology | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Protein-Serine-Threonine Kinases - genetics | Antineoplastic Combined Chemotherapy Protocols | Proto-Oncogene Proteins - genetics | Treatment Outcome | Genes, p53 - genetics | Mutation - genetics | Randomized Controlled Trials as Topic | Animals | MAP Kinase Signaling System - drug effects | Benzimidazoles - pharmacology | Fluorodeoxyglucose F18 | Biomarkers, Tumor - genetics | Mice | Clinical Trials, Phase II as Topic | Antimitotic agents | Gene mutations | Genetic aspects | Dosage and administration | Research | Lung cancer, Non-small cell | Drug therapy | Antineoplastic agents | Health aspects | Confidence intervals | Hypotheses | Clinical trials | Tomography | Mutation | Pharmaceutical industry | Drug dosages | Cancer therapies | Patients | Tumors | Apoptosis
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 10, pp. 897 - 906
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 14, pp. 1628 - 1629
Journal Article
Journal Article
Radiographics, ISSN 0271-5333, 2017, Volume 37, Issue 5, pp. 1371 - 1387
Journal Article
JAMA, ISSN 0098-7484, 02/2016, Volume 315, Issue 7, pp. 672 - 681
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2017, Volume 23, Issue 1, pp. 204 - 213
Journal Article